title: Plasma DNA integrity indicates response to neoadjuvant chemotherapy in patients with locally confined breast cancer.
authors.affiliation: Institute of Clinical Chemistry, University Hospital Munich-Grosshadern, Munich, Germany.
authors.forename: Julia
authors.initials: J
authors.lastname: Lehner
authors.forename: Oliver J
authors.initials: OJ
authors.lastname: Stötzer
authors.forename: Debora M I
authors.initials: DM
authors.lastname: Fersching
authors.forename: Dorothea
authors.initials: D
authors.lastname: Nagel
authors.forename: Stefan
authors.initials: S
authors.lastname: Holdenrieder
mesh_terms: D000970:Antineoplastic Agents / Q000097:blood / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000097:blood*; D001943:Breast Neoplasms / Q000097:blood* / Q000188:drug therapy* / Q000601:surgery; D018270:Carcinoma, Ductal, Breast / Q000097:blood / Q000188:drug therapy / Q000601:surgery; D018275:Carcinoma, Lobular / Q000097:blood / Q000188:drug therapy / Q000601:surgery; D003520:Cyclophosphamide / Q000097:blood / Q000627:therapeutic use; D004247:DNA / Q000097:blood*; D000077143:Docetaxel; D015251:Epirubicin / Q000097:blood / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D020360:Neoadjuvant Therapy / Q000379:methods*; D043823:Taxoids / Q000097:blood / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D043823:Taxoids; D000077143:Docetaxel; D015251:Epirubicin; D003520:Cyclophosphamide; D004247:DNA